Goldman Sachs lowered the firm's price target on Klaviyo to $35 from $40 and keeps a Buy rating on the shares. The company's Q1 revenue and EBIT margins topped estimates, however the stock was sharply lower as a result of weaker sequential growth and guidance suggesting this will continue into Q2, with revenue trends contrasting with positive management commentary, the analyst tells investors in a research note.
